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Abstract
Expanded polyglutamine (polyQ) proteins are known to be the causative agents of a number of human neurodegenerative
diseases but the molecular basis of their cytoxicity is still poorly understood. PolyQ tracts may impede the activity of the
proteasome, and evidence from single cell imaging suggests that the sequestration of polyQ into inclusion bodies can
reduce the proteasomal burden and promote cell survival, at least in the short term. The presence of misfolded protein also
leads to activation of stress kinases such as p38MAPK, which can be cytotoxic. The relationships of these systems are not
well understood. We have used fluorescent reporter systems imaged in living cells, and stochastic computer modeling to
explore the relationships of polyQ, p38MAPK activation, generation of reactive oxygen species (ROS), proteasome inhibition,
and inclusion body formation. In cells expressing a polyQ protein inclusion, body formation was preceded by proteasome
inhibition but cytotoxicity was greatly reduced by administration of a p38MAPK inhibitor. Computer simulations suggested
that without the generation of ROS, the proteasome inhibition and activation of p38MAPK would have significantly reduced
toxicity. Our data suggest a vicious cycle of stress kinase activation and proteasome inhibition that is ultimately lethal to
cells. There was close agreement between experimental data and the predictions of a stochastic computer model,
supporting a central role for proteasome inhibition and p38MAPK activation in inclusion body formation and ROS-mediated
cell death.
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Introduction
A hallmark feature of human neurodegenerative diseases is the
accumulation of misfolded or otherwise abnormal proteins which
become concentrated into large aggregates. Inclusion bodies are
large nuclear or cytoplasmic protein aggregates whose predomi-
nant constituents may be characteristic of particular diseases. In
many cases inclusion bodies (IB) are immunoreactive for ubiquitin
and proteasome components [1], indicative of abortive or
incomplete proteolysis. The sustained expression of mutant protein
with the propensity to misfold may ultimately overwhelm the
ubiquitin/proteasome system (UPS) and promote the formation of
inclusions. This process may be accelerated by an age-related
decline in UPS efficiency (discussed in [2]), which may explain
why genetically transmitted neurodegenerative disorders typically
affect older individuals. Consistent with the proteasome impair-
ment hypothesis, IB form in the neurons of mice in which
proteasome function has been genetically compromised [3].
Because misfolded, damaged, or genetically abnormal proteins
are aggregation-prone their sequestration into inclusion bodies
may actually alleviate the load on the UPS and promote neuronal
survival, at least in the short term. Time lapse microscopy of a
fluorescent proteasome reporter in cultured neurons has indicated
that the UPS load is partially alleviated upon IB formation [4],
and there is evidence that cultured cells forming such inclusions
have a survival benefit [5] over the course of the experiment. In
the longer term, however, it is possible that deleterious effects from
IB formation would become pronounced. Apart from potential
physical perturbations imposed by large proteinaceous inclusions
(in axons, for example) these entities may wreak havoc by
depleting essential cellular components (reviewed in [6]) or by
biochemical means. In Huntington’s disease, IB form when a
polyglutamine tract in the N-terminal region of the huntingtin
protein exceeds the threshold length of approximately forty
glutamine residues; early onset and severe disease are correlated
with very long tracts, whereas huntingtin proteins with polyglu-
tamine tracts shorter than the threshold do not form IB and are
not pathogenic [7]. The nuclear IB formed by the mutant
huntingtin protein are generators of reactive oxygen species [8],
and expression of such an expanded polyglutamine protein results
in sustained and ultimately cytotoxic activation of p38MAPK [9].
It is likely that proteasome inhibition, ROS generation, and
p38MAPK activation all feature in the death of cells containing
IB, but their relative importance and potentially complex
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interdependencies are poorly understood. We have combined live
cell imaging with mathematical modeling to explore such
relationships. Our data point to a positive feedback loop between
IB formation and p38MAPK activation that likely involves ROS.
The existence of this loop is supported by the close agreement of
laboratory data and simulations generated by a stochastic
computer model.
Results
p38MAPK inhibition rescues cells from polyglutamine-
induced cell death
We have previously demonstrated sustained activation of
p38MAPK in cultured mammalian cells expressing expanded
polyglutamine proteins and in a transgenic mouse model of
expanded-polyglutamine disease [9]. This activation could be
abrogated by treatment with the specific p38MAPK inhibitor
SKF86002. To confirm the activation of p38MAPK and its
inhibition by SKF86002 we performed western blot analysis of
U87MG cells expressing HttQ103 (an amino terminal fragment of
the human huntingtin protein containing a 103 glutamine tract).
Expression of the expanded polyglutamine protein resulted in
extensive phosphorylation of HSP-27, a downstream target of
p38MAPK (Figure 1A). Reduced phosphorylation of HSP-27 was
detected in cells expressing HttQ25 and HSP-27 phosphorylation
was undetectable in untransfected control cells. Although the
HttQ25 protein contains a polyglutamine tract below the
threshold length for pathogenicity, its overexpression upon
transfection may be sufficient to activate p38MAPK at a low
and nontoxic level as we have documented previously [9]. The
phosphorylation of HSP-27 was precluded by pre-treatment of
transfected cells with a pharmacological inhibitor of p38MAPK
(Figure 1A) or by co-expression with a dominant-negative (kinase
dead) variant of p38MAPK (Figure S1) confirming that the
phosphorylation of HSP-27 was due to the activation of the
p38MAPK pathway by Htt103.
To determine if blockade of p38MAPK activity affects cell
survival, we transfected U87MG cells with either HttQ25,
HttQ103 or a GFP control plasmid. At 30 hours post-transfection,
flow cytometry was performed using propidium iodide exclusion,
and revealed that HttQ103 expressing cells exhibited the highest
levels of death (25%, Figure 1B) whereas the death associated with
Htt25 expression was similar to that of GFP (10–12%). Pre-
treatment of HttQ25 and HttQ103cells with SKF86002 resulted
in a decrease in cell death that was most pronounced in cells
expressing HttQ103 (Figure 1B). The HttQ103 protein is known
to inhibit proteasome activity in a cell-based assay [10]; to
determine if the cytotoxicity of the expanded-polyglutamine
proteins could be enhanced by further proteasome inhibition a
pharmacological proteasome inhibitor (PI) was added to HttQ25
and HttQ103 transfected cells. Cells were pre-treated with PI for
6 hours prior to assessing cellular death by flow cytometry. PI-
Figure 1. SKF86002 rescues cells from expanded-polygluta-
mine induced cell death. A) Western blot analysis with an antibody
specific for phospho-HSP-27 in extracts from U87MG cells expressing
HttQ25 or HttQ103. Cells were untreated or were treated with the
p38MAPK inhibitor SKF86002. Expression of expanded HttQ103
activated p38MAPK and resulted in phosphorylation of HSP-27, a
downstream target of p38MAPK. The analysis revealed a significant
reduction of HSP-27 phosphorylation in HttQ25 and HttQ103 express-
ing cells treated with SKF86002. Re-probing the membrane with an
antibody raised against total-HSP-27 revealed no significant difference
in the total levels of HSP-27 protein. Actin served as a loading control. B)
Cell viability of U87MG cells expressing GFP, HttQ25 or HttQ103 treated
with proteasome inhibitor (PI) or p38MAPK inhibitor (SKF86002) was
assessed by flow cytometry analysis using propidium iodide exclusion.
The survival of SKF86002 treated HttQ103 expressing cells was
significantly improved when compared to untreated counterparts.
Treatment with PI resulted in a significant increase in cell death in cells
expressing HttQ103 when compared to HttQ25 expressors. Error bars
indicate the standard error of the mean (*p,0.05).
doi:10.1371/journal.pcbi.1000944.g001
Author Summary
Neurodegenerative diseases feature concentration of
misfolded or damaged proteins into inclusion bodies.
There is controversy over whether these entities are
protective, detrimental, or relatively benign. The formation
of inclusion bodies may be accelerated by inefficient
protein degradation and may promote activation of stress
signalling pathways. Each of these events may promote
the generation of reactive oxygen species which may
exacerbate the problem by damaging more proteins,
possibly damaging components of the UPS itself, but in
either case further impeding the function of cellular
proteolytic systems. To determine how these events are
related and which are critical, we generated a live cell
imaging system in which inclusion formation and proteo-
lytic efficiency can be evaluated, and created a stochastic
computer model incorporating the same components.
Laboratory data and computer simulations were found to
be in close agreement, supporting a mechanism wherein
misfolded protein induced a vicious cycle of stress kinase
activation, ROS generation, and proteasome inhibition
which was ultimately cytotoxic. Inclusion body formation
partially alleviated the burden on the proteolytic system,
but may not provide long term benefit. Pharmacological
blockade of a stress-activated kinase was effective in
breaking the vicious cycle, as predicted by the computer
model and confirmed experimentally.
PolyQ-Mediated Cytotoxicity
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treated U87MG cells expressing HttQ103 exhibited a significant
increase in cell death when compared to their untreated
counterparts (Figure 1B), and was 15% greater than PI treated
HttQ25 expressing cells. Under the same experimental conditions
the amount of cell death induced by PI in untransfected cells was
approximately 5% (not shown), roughly equivalent to the increase
in cell death mediated by PI in cells expressing HttQ25 and
HttQ103. Under our conditions proteasomes cannot therefore be
fully inhibited by expression of the polyQ proteins alone. The
pharmacological data support the argument that the cytotoxicity
of misfolded proteins is mediated by proteasome inhibition and
p38MAPK activation, but do not reveal whether these activities
are independent.
IB formation is promoted by p38MAPK activity, and
proteasome dysfunction
To simultaneously assess functioning of the UPS and inclusion
body (IB) formation at a single cell level we created a bicistronic
construct that encodes an expanded polyglutamine protein and
fluorescent proteasome substrate on the same transcript (see
schematic diagram in Figure 2A). This construct was designed to
investigate the temporal order of events leading to HttQ103
induced cellular and proteasome toxicities and to dissect the role of
p38MAPK in these events.
U87MG cells were transfected with HttQ103YFP-pIRES-
mRFPu and were imaged at 10 minute intervals from 24 to
48 hours post-transfection. The time lapse images revealed
formation of IB at 36 hours post-transfection in cells expressing
HttQ103 (Figure 2B, first panel; time lapse videos are provided as
Videos S1 to S8). Values of mRFPu intensity were graphed as a
function of time revealing an increase in mRFPu fluorescence prior
to the formation of an IB, followed by a period of constant mRFPu
intensity. The single cell analysis revealed that HttQ103-induced
cellular death is preceded by gradual UPS impairment. Once this
impairment reaches a threshold level, IBs begin to form and their
formation correlates with a momentary recovery of UPS efficiency
as measured by mRFPu intensity. These results are consistent with
previously published findings in primary neuron cultures [4].
To examine the extent to which IB formation was dependent on
UPS dysfunction U87MG cells expressing HttQ103YFP-pIRES-
mRFPu were treated with proteasome inhibitor. As expected PI
treatment resulted in a rapid and persistent increase in mRFPu
intensity. Under these conditions IB formation was accelerated
relative to untreated controls (Figure 2B, second panel). These
data suggest an immediate relationship between proteasomal
inhibition and IB formation.
Damaged proteins are normally eliminated by the UPS, and we
speculated that an increase in cellular ROS levels would lead to
oxidative damage to proteins and inflict an additional burden on
proteasomes that may affect the kinetics of IB formation. To test
this hypothesis, we depleted reduced glutathione levels in
HttQ103YFP-pIRES-mRFPu tranfected cells by treating cells
with buthionine sulphoximine (BSO) at 24 hours post-transfection.
In BSO treated cells we observed a constant increase in mRFPu
intensity (Figure 2B, third panel) consistent with a cumulative UPS
burden.
Having previously established that the activation of p38MAPK
in HttQ103 expressing cells contributes to cytotoxicity, we sought
to determine what effects inhibition of p38MAPK signalling
pathway would have on IB formation and UPS dysfunction.
U87MG cells expressing HttQ103YFP-pIRES-mRFPu were
therefore treated with SKF86002. These cells exhibited a low
level of mRFPu fluorescence along with a delay in IB formation
(Figure 2B, fourth panel). The mRFPu fluorescence remained low
and did not feature a rapid increase as seen in the untreated
counterparts. These data suggest that inhibition of the p38MAPK
pathway decouples the proteasome inhibition from HttQ103
protein expression, resulting in delayed formation of IB.
We quantified IB formation by recording the number of cells
with IB at 6 hour intervals starting at 24 hours post-transfection.
The percentage of cells with IB was graphed as a function of time
(Figure 3A). PI treatment generated the greatest number of IB
compared to untreated cells while SKF86002-treated cells were
found to have the fewest IB. Comparative single-cell analysis of IB
formation corresponded to time-points in which 40% of
transfected cells had formed IB. Similarly, we quantified average
mRFPu fluorescence from many cells and graphed the fluores-
cence intensities as a function of time. Treatment with PI and BSO
generated the highest amounts of mRFPu fluorescence, while
SKF86002 treatment resulted in the lowest levels of mRFPu in
comparison to untreated cells (Figure 3B). Findings from multiple
cells were consistent with the mRFPu fluorescence levels observed
in the single cell analysis.
The critical role of p38MAPK is supported by
mathematical modeling
We have previously used stochastic computer modeling to study
the age-related decline of proteolysis [11], and have adapted this
model to incorporate p38MAPK in an effort to better understand
polyglutamine-mediated cell death. Our objective was to deter-
mine if a relatively simple mathematical model incorporating the
components thought to be critical for polyQ-mediated cytotoxicity
could recapitulate our laboratory findings; if not some critical
component must have been overlooked or one or more of the
starting assumptions must be invalid. Conversely, a good fit would
suggest that the assumptions are valid and no critical elements
have been overlooked. The stochastic computer model is
represented schematically in Figure 4. The model was constructed
using the Systems Biology Markup Language as described in the
Materials and Methods section; details of molecular species and
reactions are given in Text S1. The model predicted that
treatment with PI would lead to reduced cell death at 30 hours
(Figure 5A), a short term benefit from reduced levels of small
aggregates binding to proteasomes (the consequence of which
would be reduced by concentration of aggregates into IB). The
experimental data, however, indicated a slight increase in the
proportion of cell deaths under PI suggesting that the situation is
more complex than is currently accounted for in the model. On
the other hand, the model predicted that inhibition of p38MAPK
activity should lead to much lower cell death, in close agreement
with the experimental data. Also in agreement with the
experimental findings described above, the model predicted that
proteasome inhibition should lead to an increase in the rate of IB
formation compared to untreated cells (Figure 5B). When
p38MAPK activity is inhibited the model predicts a lower rate
of IB formation at early time-points (Figure 5B) although from 36–
48h, the rate of increase is similar to untreated cells (note lines are
parallel for polyglutamine and p38MAPK inhibition during this
time interval). The later increase in inclusion formation when
p38MAPK activity is inhibited is probably due to ROS generation
via the aggregated protein. The computer model predicts that
much higher levels of mRFPu will be observed in PI treated cells
than in untreated cells, as expected for a proteasome substrate
(Figure 5C). Critically, inhibition of p38MAPK activity reduced
the accumulation of mRFPu in the computer model. Overall the
simulations and experimental data are in good agreement,
indicating that the model describes the important molecular
relationships of the system as portrayed in Figure 4.
PolyQ-Mediated Cytotoxicity
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Figure 2. Expression of HttQ103 results in the formation of inclusion bodies (IB) that are preceded by increased levels of the
proteasome reporter protein mRFPu. A) Schematic representation of the bicistronic expression construct engineered to simultaneously express
the huntingtin-derived protein HttQ103 fused to the yellow fluorescent protein (YFP) and an intrinsic proteasome activity reporter (mRFPu)
downstream of an internal ribosome entry site (IRES). B) Single cell analysis of IB formation and UPS impairment induced by the expression of the
HttQ103 protein. U87MG cells expressing HttQ103YFP-pIRES-mRFPu were imaged over the course of 24 hours to simultaneously follow IB formation
and UPS impairment. Cells were either left untreated (panel 1) or treated with proteasome inhibitor (panel 2), buthionine sulphoximine (BSO, panel 3)
or the p38MAPK inhibitor (SKF86002, panel 4) and visualized under fluorescence at 10 minute intervals. Over time accumulation of mRFPu was
graphed using densitometry values from a single cell for each condition which revealed detectible levels of mRFPu prior to the formation of an IB
(represented by the yellow arrow). Treatment with PI resulted in IB formation at an earlier time-point and correlated with increased levels of mRFPu.
BSO treatment also increased mRFPu levels but did not significantly accelerate the timing of IB formation. Treatment with SKF86002 resulted in
overall lower levels of mRFPu and a delay in inclusion body formation. Single cells were isolated from the population of cells described in Figure 3.
doi:10.1371/journal.pcbi.1000944.g002
PolyQ-Mediated Cytotoxicity
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Activation of p38MAPK contributes to ROS production
but not direct proteasome inhibition
Based on our single-cell analysis data, we speculated that the
activation of p38MAPK and UPS impairment were contributing
to the production of reactive oxygen species (ROS) and that
SKF86002 may be counteracting this cellular response. A genetic
approach was adopted to test this hypothesis, utilizing transfection
of cells with expression vectors encoding wild type or kinase dead
versions of p38MAPK. Whereas pharmacological inhibition may
affect multiple p38MAPK isoforms any modulation of cellular
response observed with the genetic approach would be attributable
to the alpha isoform of p38MAPK exclusively. We first confirmed
that in our U87MG cell system the expression vectors were
capable of modulating p38MAPK activity using phosphorylation
of HSP27 as a proxy marker (Figure S1). Cells were then
transfected with the p38MAPK expression vectors or with an
empty vector control construct and lysates were assayed for
reduced glutathione (GSH) content, a marker of oxidative status
within cells. We found that overexpression of wild type p38MAPK
resulted in a significant decrease in GSH levels whereas the GSH
content in cells expressing kinase dead p38MAPK was less affected
in comparison to controls (Figure 6A). To determine if
overexpression of wild type p38MAPK resulted in dysfunction of
the UPS, we transfected the p38MAPK expression constructs into
a cell line stably expressing GFPu, a well characterized proteasome
sensor [10]. For these experiments we made use of a stable NIH
3T3 cell line we had previously generated; the GFPu reporter is
expressed at a lower level in the stable line and does not
accumulate as an artefact of transfection-mediated overexpression.
By flow cytometric analysis, we found that cells overexpressing
wild type p38MAPK exhibited the highest levels of GFPu intensity
whereas the levels of GFPu in cells expressing the kinase dead
p38MAPK or the empty vector were similar (Figure 6B). These
data suggested that the activation of p38MAPK was negatively
affecting UPS function. To test whether this inhibition of the
proteasome was a direct affect of p38MAPK activation, we
transfected cells with the same set of plasmids and assayed their
proteasome activity using fluorogenic substrates. No significant
differences were noted (Figure S1). Taken together, the data
indicate that the expression of p38MAPK does affect the oxidative
status of cells but does not directly inhibit the proteasome.
Since aggregated protein leads to increased levels of ROS,
inhibition of p38MAPK may simply delay cell death and thereby
allow more aggregation to take place. To determine the predicted
outcome should p38MAPK not be involved in generating more
ROS we removed the reaction for ROS generation via p38MAPK
from the model and repeated the computer simulations. Without
p38MAPK-generated ROS less cell death was predicted under all
conditions (Figure 7A). With the feedback loop broken in this way
the model also predicted that there would be no significant
difference in the numbers of inclusions at each time point between
untreated cells and cells treated with a p38MAPK inhibitor
(Figure 7B). We also refitted the model for HttQ103 without
treatments and no feedback loop using the experimental data for
cell death and inclusion formation (Figure 7C–D). Since the model
predicted less cell deaths and lower levels of inclusions than the
data, we increased the parameters for inclusion formation (kaggPolyQ)
and cell death (kp38death and kPIdeath). We also increased the
parameter for ROS generation via p38MAPK (kgenROSp38) since
this had the effect of increasing both the levels of inclusions and
the number of cell deaths. We then ran the model with the
treatment for proteasome inhibition and p38MAPK inhibition.
The model was not able to reproduce the decline in cell death or
the lower levels of inclusions when p38MAPK is inhibited (evident
from the comparison of Figure 7C–D with Figure 5A–B).
Therefore the model indicates that a feedback loop from
p38MAPK to ROS is required to explain the experimental data.
Discussion
Based on the experimental data and the computer simulations
reported herein we propose a vicious cycle mechanism of
polyglutamine-mediated cytotoxicity (Figure 8). In the proposed
mechanism the initiating event is the inhibition of the proteasome
by small aggregates of misfolded protein. It has been previously
shown that proteasome inhibition leads to the generation of ROS
(reviewed in [12]) and the activation of MKK3 and MKK6 kinases
Figure 3. Data from multiple live cell analyses of IB formation and proteasome inhibition. A) The percentage of IB formation for each
treatment was recorded every 6 hours beginning at 24 hours post-transfection. B) Average mRFPu intensity values for multiple cells over time.
Experiments were performed in triplicate with over 50 cells analyzed in each condition. Error bars indicate standard error of the mean.
doi:10.1371/journal.pcbi.1000944.g003
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Figure 4. Diagram of molecular relationships simulated in the computer model. The model assumptions are presented in Text S1, along
with lists of molecular species (Table S1 in Text S1) and reaction parameters (Table S2 in Text S1).
doi:10.1371/journal.pcbi.1000944.g004
PolyQ-Mediated Cytotoxicity
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upstream of the stress kinase p38MAPK [13,14]. Activation of
p38MAPK by its upstream regulators may exacerbate the problem
by promoting downstream ROS production (through a mecha-
nism discussed below). By damaging other cellular proteins the
reactive oxygen would provide an additional burden to the UPS,
which is normally charged with the proteolytic degradation of
damaged or abnormal proteins. Increasing proteasome inhibition
would lead to further accumulation of misfolded proteins,
ultimately coalescing into inclusion bodies. By reducing local
concentrations of the small aggregates that are thought to be most
inhibitory to the proteasome the IBs may temporarily alleviate
proteasome inhibition, but by concentrating iron they may
promote the further generation of ROS, ensuring yet more
damage and the conditions that will sustain p38MAPK activation.
Whether or not there is self-amplification of the vicious cycle as a
consequence of increasing ROS production we postulate that it is
sustained p38MAPK activity and proteasome inhibition that will
ultimately lead to cell death.
The mathematical model was based on our previous model of
the ubiquitin/proteasome system which we modified and extended
to include turnover and aggregation of polyglutamine proteins.
The model predictions were in close agreement with the
experimental data indicating that the proposed network in
Figure 4 captures the important components in the system.
However, we found that there were some discrepancies between
the model predictions and experimental data regarding cell death
at early time-points under conditions of proteasome inhibition.
This suggests that there is something missing from the model.
Since proteasome inhibition affects all protein turnover, the
missing part could be a pro-apoptotic protein. One such candidate
is the transcription factor p53 which is normally rapidly turned
over by the proteasome. A future extension of our current model
to include a pro-apoptotic protein would be fairly straightforward
as we have previously modelled the p53 system [15]. An advantage
of modelling over laboratory experiments is that it is easy to
manipulate the system on a computer, whereas the same
experiments in the laboratory may be impossible or very costly
to do. For example, although it would be difficult to prove
experimentally that ROS generation by p38MAPK is required to
explain the experimental data, the hypothesis could easily be tested
in the mathematical model by simply removing the reaction of
p38MAPK-dependent ROS generation and repeating the simu-
lations. The model confirmed that p38MAPK is involved in
generating more ROS since with the feedback loop broken the
model output no longer fitted the experimental data.
We have previously shown that pharmacological blockade of
p38MAPK can protect cells from polyglutamine-mediated cell
death [9], and the current experimental data and mathematical
modeling provide an explanation for the efficacy of this
intervention: by breaking the vicious cycle the p38MAPK
inhibitor precludes further damage and proteasome inhibition.
The data we present herein support a central role for ROS in the
proposed cycle of p38MAPK activation, proteasome inhibition,
and protein aggregation that ultimately leads to cell death. The
importance of ROS in protein misfolding disorders is not a new
concept; indeed the cytotoxicity of elevated ROS generated by
mutant huntingtin has been convincingly demonstrated by the
laboratory of Rubinsztein [16]. Intriguingly, the proteasome is
itself an important regulator of oxidative damage in neurons and
proteasome inhibition is known to induce mitochondrial dysfunc-
tion and promote oxidative damage to DNA and protein (reviewed
in [12]). Once some threshold of polyQ-mediated proteasome
inhibition is reached it seems entirely plausible that a self-
perpetuating loop of ROS generation and p38MAPK activation
could lock the cell into a dysfunctional state. Indeed, a directly
analogous positive feedback loop involving ROS and p38MAPK
activation was recently proposed for the induction of senescence in
Figure 5. Simulations generated by a stochastic computer
model of polyglutamine-mediated cytotoxicity. A) Model pre-
dictions for cell death at 30 hours. Results show percentage of cells that
died by 30 hours in 300 simulations of each computer experiment. B)
Model predictions for kinetics of inclusion formation. Results show
percentage of cells with inclusions at each time point from 300
simulations for each computer experiment. C) Model predictions for
accumulation of mRFPu. The mean level of mRFPu for 300 simulations of
each computer experiment was calculated for each of the time-points
shown. The y-axis shows the number of molecules predicted by the
simulations. Error bars for the model predictions represent standard
error of the mean.
doi:10.1371/journal.pcbi.1000944.g005
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mammalian cells. By combining bioinformatics, stochastic com-
puter modeling, and direct experimental interventions Passos et al.
have provided convincing evidence that sustained activation of
p38MAPK is required for generation of mitochondrial ROS,
which by generating DNA damage ensures the continued
activation of p38MAPK in senescent cells [17]. The ROS
generated as a consequence of proteasome inhibition also appears
to be of mitochondrial origin [18], so the cascade of events in cells
expressing misfolded protein may be very similar to that in cells in
which the initiating event is exposure to ionizing radiation (as was
the case in the Passos paper). If a similar loop were operating in
cells expressing expanded polyglutamine proteins one might
expect to find ROS-mediated DNA damage leading to activation
of ATM and phosphorylation of histone H2AX, as has indeed
been documented in cells from Huntington’s disease and SCA-2
patients [19]. The activation of ATM and formation of H2AX
repair foci appears to precede the formation of IB [20], but may be
coincident with p38MAPK activation and the generation of ROS.
If our model is correct pretreatment of cells with the p38MAPK
inhibitor should reduce the number of H2AX foci in cells
expressing HttQ103. We are currently testing this hypothesis.
Enhanced levels of autophagy may also contribute to the
protective effects of the p38MAPK inhibitor we have observed.
Although the effects may be dependent on cell type, there is
evidence that the alpha isoform of p38MAPK inhibits autophagy
[21] [note that this is the same isoform utilized in our genetic
experiments, and may be the target of primary importance to all of
the interventions described herein]. Low level inhibition of the
proteasome is known to promote autophagy [22], but as
proteasome inhibition increases the activation of p38MAPK may
limit autophagic clearance of protein aggregates. Enhancement of
autophagy has been proposed as a therapeutic strategy for the
treatment of polyglutamine disorders such as Huntington’s disease
[23], and pharmacological blockade of p38MAPK may provide
benefit by multiple mechanisms. It may break the vicious cycle of
ROS generation while promoting autophagy-mediated clearance
of aggregates in cells already compromised for proteasome
function.
We have performed the current set of experiments in U87MG
cells, a human glioblastoma cell line. These cells were chosen for
their ease of handling, including their high transfection efficiency.
Because the critical components of the proposed vicious cycle are
universally present in mammalian cells (including p38MAPK,
proteasomes, and ROS from mitochondria) it is likely that a self-
perpetuating loop could be triggered by expanded polyglutamine
proteins in any cell type, and we have previously demonstrated the
protective effect of a p38MAPK inhibitor in normal and
transformed cells of both human and mouse origin [9]. We
nevertheless recognize that the kinetics of the events we have
described may be markedly different for neurons in situ.
Although the short term benefit of IB formation (through
improved proteasome function) has been demonstrated in cultured
neurons [4,5] the longer term implications of IB in neurodegen-
erative diseases must be considered. A transient alleviation by IB of
the polyglutamine-mediated proteasome burden was recently
demonstrated in vivo in an inducible model of Huntington’s disease
[24], but no long term impairment of proteasome function was
observed in the brains of these mice. If the IB concentrates iron
and promotes ROS generation through Fenton chemistry [8] the
IB, once formed, might ensure the perpetuation of the vicious
cycle proposed in Figure 3C. The failure to detect this effect in
older mice expressing a polyQ protein may relate to the inability of
the reporter system to detect less than a 40% decrease in
proteasome inhibition [24] or may relate to differences between
the mouse model and the human disease. In human polyglutamine
disorders the disease may progress over years if not decades, and
the later consequences of IB formation might therefore be more
severe. Clinical evidence supports a deleterious role for IB in
human disease. In polyglutamine repeat diseases such as HD,
frontotemporal lobar degeneration, and RNA-mediated diseases
Figure 6. Effects of p38MAPK activity on GSH and GFPu levels. A) Lysates from cells expressing either wild type p38MAPK, kinase dead
p38MAPK, or pcDNA control plasmids were assayed for reduced GSH content 48 hours post transfection. Cells transfected with wild type p38MAPK
had lower levels of reduced GSH when compared to the pcDNA empty vector control (**p,0.05) and kinase dead p38MAPK expressing cells
(*p = 0.06). B) Activation of the p38MAPK pathway leads to proteasomal inhibition. Wild type p38MAPK or kinase dead p38MAPK were transfected
into 3T3 cells stably expressing the proteasome reporter GFPu. Cells were collected at 48 hours post-transfection and GFPu intensity was analyzed by
flow cytometric analysis. Cells over-expressing wild type p38MAPK had significantly higher levels of GFPu accumulation when compared to cells
expressing kinase dead p38MAPK (*p,0.05) or pcDNA empty vector control (**p,0.01). PI treatment served as a positive control.
doi:10.1371/journal.pcbi.1000944.g006
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such as myotonic dystrophy, inclusion-mediated titration of
transcription factors (like CBP), tar DNA-binding protein 43
(TDP-43), and RNA splicing factors (for example muscleblind),
respectively, may represent an important molecular mechanism of
disease [6]. Added to these effects would be the deleterious effects
we ascribe to the ROS-mediated vicious cycle.
Materials and Methods
Expression constructs
The pEGFP-N1 expression construct was purchased from
Clontech (Palo Alto, California, USA). Htt-Q25 and Htt-Q103
expression constructs containing a synthetic insert encoding exon
1 or human Huntingtin containing a polyglutamine tract of either
25Q or 103Q fused to the yellow fluorescent reporter protein
(YFP) were generous gifts from Dr. Ron Kopito (Stanford
University). These are designated HttQ25YFP or HttQ103YFP.
A red fluorescent proteasome reporter was generated by PCR-
mediated transfer of the degron sequence from the GFPU
reporter (Bence et al.; the gift of Dr. Ron Kopito) to the C
terminus of the monomeric red fluorescent protein (the gift of Dr.
Robert Campbell, University of Alberta). Under normal condi-
tions, mRFPu is quickly degraded by the 26S proteasome, but
during conditions of proteasomal impairment, turnover of
Figure 7. Simulated effects of p38MAPK activation without ROS generation. A) When the feedback loop is broken by eliminating ROS
production the model predicts that cell death will be reduced under all conditions. B) Under ROS-free conditions the model predicts no significant
difference in the numbers of inclusions at each time point between untreated polyglutamine-expressing cells or cells treated with a p38MAPK
inhibitor. Similarly, no significant difference is predicted in the number of inclusions at early time points between untreated cells or cells treated with
a proteasome inhibitor. At later time points (.= 42h) more inclusions are predicted for the PI treated cells due to the accumulation of misfolded
protein which cannot be degraded. C) Model re-fitted to data of untreated poly-glutamine-expressing cells predicts more cell deaths but still no
significant differences between treatments. D) Model re-fitted to data of untreated poly-glutamine-expressing cells shows no significant differences
between untreated and treated cells at early time points. At 48h, the model predicts a small but significant increase in the number of inclusions for
cells treated with p38MAPK inhibitor indicating that the model no longer fits the data. The error bars represent the standard error of the percentage
given by
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
p(100{p)=n
p
where n is the number of simulation runs (n = 300) and p is the percentage of cells.
doi:10.1371/journal.pcbi.1000944.g007
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mRFPu is reduced, leading to an accumulation of mRFPu that is
visible by fluorescent microscopy. To simultaneously express the
expanded YFP-tagged polyglutamine proteins and the red
fluorescent proteasome reporter the former was inserted into
NheI site upstream of the internal ribosome entry site (IRES) in
the vector pIRES (Clontech, Palo Alto, California, USA) and the
latter was inserted between the Xba I and Sal I sites downstream
of the IRES element. The wild type and kinase dead p38MAPK
variants were generous gifts from Dr. J. Han (The Scripps
Research Institute, La Jolla, CA). The hyper-active p38MAPK
construct was a gift from Dr. Oded Livnah (The Hebrew
University of Jerusalem).
Cell culture and transfections
The human U87MG glioblastoma cells (a gift from Dr. I.
Lorimer at the Ottawa Hospital Research Institute) were
maintained in Dulbecco’s modified Eagle’s medium (DMEM)
and supplemented with 10% FBS and maintained in a 37uC
incubator with 5% CO2. For transient transfections, cells were
plated in either 96- or 6 well dishes 24hours prior to
transfections. Subsequently, they were transfected using Gene-
Juice Transfection Reagent (Novagen, Madison, WI, USA) as
per the supplier’s protocol. 0.5mg or 3.0mg of plasmid DNA was
used in each well of a 96 or 6 well dish. For p38MAPK
inhibition experiments, cells were pre-treated for 2h with 20mM
SKF86002 (Calbiochem) prior to transfection with various
expression constructs.
Western blot analysis
U87MG cells were harvested in protein lysis buffer consisting of
100mM Tris pH 6.8, 20mM DTT, 4% SDS, 5% glycerol. Protein
concentrations were determined using the Bradford assay reagents
(Bio-Rad, Hercules, CA, USA). Reduced proteins were resolved
on a 10% SDS-polyacrylamide gel and electro-blotted onto a
Hybond C nitrocellulose membrane (Amersham Bioscience Corp,
Baie d’Urfe´, QC). The membranes were stained with Ponceau S
prior to immunoblotting with phospho-HSP-27 (polyclonal
rabbit), total HSP-27 (rabbit polyclonal) (Cell Signaling, Danvers,
MA), or Actin (Sigma-Aldrich). Proteins were detected using the
HRP method and SuperSignal West Pico Chemiluminescent
Substrate reagents (Pierce, Rockford, IL, USA). Proteins were
visualized using the GeneGnome (Syngene, Frederick, MD, USA).
Survival assays
Cell viability was assessed by flow cytometry using propidium
iodide exclusion. Adherent and non-adherent cells were transfect-
ed with various constructs for 30 hours, harvested and stained with
Propidium Iodide. For p38MAPK inhibition experiments, cells
were pre-treated for 2h with 20mM SKF86002 (Calbiochem) prior
to transfection with various expression constructs. For proteasome
inhibition experiments, cells were treated with Proteasome
Inhibitor I (Calbiochem) 24h post-transfection at a final concen-
tration of 25mM. Fluorescent detection was analyzed by flow
cytometry using a Beckman Coulter Quanta SC MPL. Data and
Figure 8. Proposed model of expanded-polyglutamine induced toxicity. A) Expression of expanded-polyglutamine proteins leads to
proteasome inhibition, promoting the generation of ROS. This in turn leads to p38MAPK activation (which can be blocked by pretreatment of cells
with SKF86002) and the further generation of ROS through a mechanism which is likely to involve mitochondria. An increased burden of oxidatively
damaged proteins leads to further proteasome impairment, and yet more ROS generation. B) Proteasome impairment ultimately leads to inclusion
formation, which temporarily reduces UPS dysfunction. IBs perpetuate ROS production through concentration of iron, ensuring continued activation
of p38MAPK. Pharmocological inhibitors of p38MAPK such as SKF86002 can preclude the initiation of the vicious cycle or potentially interrupt it at a
later stage.
doi:10.1371/journal.pcbi.1000944.g008
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analysis were done using Quanta Analysis software (Beckman
Coulter, Inc., Brea, CA, USA).
Live-cell imaging
75 000 U87MG glioblastoma cells were seeded onto a Delta T4
culture dish system (Bioptechs, Butler, PA) andmaintained in a 37uC
incubator with 5% CO2 for 24h hours. Cells were transfected with
2ug of plasmid DNA encoding HttQ103YFP-pIRES-mRFPu for
24 hours before being transferred onto a heated stage maintained at
37uC and at 5% CO2 using a Delta T4 culture dish temperature
controller and cell perfusion system (Bioptechs, Butler, PA). For
p38MAPK inhibition experiments, cells were pre-treated for 2h with
SKF86002 for a final concentration of 20mM to preclude kinase
activation upon transfection. For proteasome inhibition experiments,
cells were treated with Proteasome Inhibitor I (Calbiochem) 24h
post-transfection at a final concentration of 25mM (treatment with PI
prior to transfection is not possible due to its immediate toxicity). For
buthionine sulphoximide (BSO)-induced depletion of glutathione
experiments, cells were treated 24h post-transfection with BSO
(Sigma) 24h post-transfection at a final concentration of 5mM.
Microscopy was performed 24 hours post-transfection on a Zeiss
Axiovert 200M inverted fluorescent microscope for a total of
24 hours. Fully automated multidimensional acquisition was
controlled using Axiovision 4.8 software. Images were acquired
using a 106 objective (EC Plan-Neofluar) with a side-mounted
AxiocamHRm camera. Yellow fluorescent protein or red fluorescent
protein was excited using the Zeiss Colibri LED illumination system
(LEDmodule 505nm or LEDmodule 590nm) and detected using the
appropriate filters (46HEYFP or 61HEGFP/HcRED, respectively).
Fixed exposure times were as follows: Brightfield phase contrast 1ms;
YFP 100ms; RFP 188ms. Images were taken at 10 minute intervals
for 48 hours and compiled into video files using Axiovision 4.8
software (Carl Zeiss, Thornwood, NY).
Glutathione assay
Cell lysates from U87MG cells over-expressing wild type
p38MAPK or kinase dead p38MAPK were analyzed for reduced
GSH content using a luciferase kit (GSH-Glo) from Promega
(Madison, WI). 10,000 cells were seeded in 96-well plates and
transfected with 0.5mg of DNA for 48 hours. Cells were collected
and analyzed for GSH following the manufacture’s protocol.
Proteasome inhibition analysis
Mouse NIH 3T3 cells were co-transfected with GFPu and a
PGK-driven puromycin resistance gene (gift of Dr. M. McBurney,
Ottawa Hospital Research Institute). Cells stably expressing the
proteasome reporter GFPu were selected over 2 weeks in a final
concentration of 2.0mg/ml. For proteasome assays, wild type
p38MAPK, kinase dead p38MAPK, or pcDNA were transfected
into 3T3-GFPu cells for 48 hours. Cells were collected and
analyzed for GFPu expression by flow cytometry (Beckman
Coulter Quanta SC MPL). Mean GFP intensity was analyzed
using the Quanta Analysis software and subsequently graphed
using Excel (Microsoft).
Statistical analysis
Statistical significance was determined by a two tailed Student’s
t-test. Unless otherwise indicated, values were considered signif-
icant when p,0.05.
Mathematical model
The model was developed to mimic the experimental system so
that simulations could be performed to see which parameters
affected the different cellular outcomes. The model was initially
fitted to experimental data where HttQ103 had been added to
cells but without any inhibitors. The model was then used to
mimic the experimental treatments and the model predictions
were compared to the experimental results. If there were
discrepancies between the model predictions and experimental
results, the model was modified (either by changing parameter
values or by the addition of further reactions). The model was then
re-run for the experiment without any treatments to check that it
still fitted the experimental data. If the model did not fit, further
adjustments were made and the procedure repeated. We originally
started with a model that did not contain a feedback loop from
p38MAPK to ROS but found that it was necessary to include this
loop in order to get the model to fit both the data for the treatment
with p38MAPK inhibitor and the data without the treatment.
Further details are given in Text S1.
The model was encoded in the Systems Biology Markup
Language (SBML) as this standard allows models to be easily
shared, modified and extended [25]. SBML is a way of
representing a network of interactions so that it can be simulated
on a computer and the evolution of the system over time can be
followed. SBML shorthand was used to create the SBML code
which was then converted into full SBML [26]. The network
diagram is given in Figure 4, and Tables S1 and S2 in Text S1 give
details of the species and reactions respectively. Text S1 also
contains more detail of events and parameter values (Tables S3
and S4 in Text S1). Since there is large variability in cellular
outcomes in terms of both inclusion formation and cell death, we
used stochastic simulation. This was based on the Gillespie
algorithm [27] which assumes that collisions of molecules occur
within a reaction vessel and that at most only two molecules can
collide. We chose this method of simulation as there are low copy
numbers of many of the species and random effects play a major
role in this model, as can be seen by the cell to cell variability of
the model output. It should be noted that we have a few reactions
which have more than two molecules in the list of reactants. These
are the reactions for the aggregation of polyQ where we assume
that ROS affects the reaction kinetics although ROS itself is not
consumed by the reaction (and so also appears in the list of
products). We use a function of ROS in the kinetic law so that we
have a pseudo second order reaction rather than a third order
reaction. Although this may seem to be a violation of the
assumptions of the Gillespie algorithm, this provides a simple way
to allow for the effects of ROS on the aggregation process rather
than adding many more reactions and parameters. The model is
available from the Biology of Ageing e-Science Simulation and
Integration (BASIS) system ([28,29]) and the Biomodels database
(ID:MODEL1002250000) [30].
Model Assumptions
We assume that the addition of the polyQ gene to the cell
resulted in continuous synthesis of the polyQ protein. It is also
degraded by the proteasome so that total levels remain fairly
constant with a half-life of about 20 hours [31]. We set the levels of
polyQ sythesis and degradation so that the half-life would be
20 hours if the proteasome did not become inhibited by
aggregates. Two molecules of polyQ interact to form a small
aggregate (AggPolyQ1). We assume that ROS affects the
aggregation kinetics if it rises above basal levels. The aggregate
can grow in size by the addition of further polyQ proteins in a
reversible manner. However, when the aggregate reaches a certain
threshold size, we assume that disaggregation can no longer take
place and that instead an inclusion forms (SeqAggP). This
threshold represents the seed and is assumed to be of size six
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based on data for amyloid fibril polymerization [32]. Since mutant
huntingtin forms amyloid-like filaments, it is reasonable to assume
that it has similar aggregation kinetics [33,34]. A very recent study
shows that mutant huntingtin forms three major pools: monomers,
oligomers and inclusion bodies [35]. Interestingly, the study
showed that the pool of oligomers as a proportion of total
huntingtin did not change over a time period of 3 days despite
continued conversion of monomer to inclusion bodies. We also
compared the levels of oligomers (represented by the species
AggPolyQ[i], where i = 1–5) in our simulation output in cells
which formed inclusion bodies (Figure S2) and discuss the results
in the Text S1 section. It has been shown that small aggregates
bind to proteasomes and inhibit proteasomal function [36].
Therefore, we assume that AggPolyQ can bind to the proteasome
and so reduce the pool of available proteasomes. However we
assume that inclusions do not interfere with the degradation
machinery. We also include a species to represent mRFPu and
assume that this is turned over with a half-life of about 30 minutes
[36]. We assume that ROS is continuously generated and
removed with a half-life of 1 hour [37] but that basal levels are
low (about 10 molecules). We assume that small aggregates may
generate ROS, so that the level of ROS is dependent on the
amount of small aggregates (either bound to the proteasome or
free pools). We also assume that the presence of inclusions will
increase levels of ROS but with a much smaller effect than small
aggregates. We represent p38MAPK in two forms: unpho-
sphorylated (p38) and phosphorylated (p38-P) with p38-P being
the active state. We assume that high levels of ROS activate
p38MAPK and that high levels of p38-P initiate a signalling
cascade that results in cell death. We set the rate of this reaction so
that it is unlikely to occur when p38-P levels are low and the
probability of the reaction occurring increases with increasing
levels of p38-P. However, since the model is stochastic, it is
possible that even low levels of p38-P will occasionally signal for
cell death. We also assume that if the level of proteasomes bound
by aggregates increases above a threshold of about 50%, then
another signalling pathway leads to cell death due to the
accumulation of the pro-apoptotic protein p53. As in the p38
death pathway, cell death due to aggregates inhibiting the
proteasome may occur even when levels of AggP Proteasome
are fairly low. The reactions for the cell death pathways are shown
in Table S2 in Text S1. After cell death occurs, a dummy
parameter kalive is set to zero to prevent further reactions occurring,
and a dummy species to record the cause of cell death is set to 1.
This makes it possible to plot the time of cell death, the cause of
death and to count the number of cell deaths of each type in
multiple simulations.
We also assume that proteasomes bound by AggP, polyQ or
mRFPu may be sequestered into inclusions if degradation does not
take place. If AggP is sequestered into inclusions, then this will help
alleviate the increase in ROS due to protein aggregation, since we
assume that small aggregates lead to greater ROS generation than
inclusions.
We also include a generic pool of protein (NatP) which can
misfold to become (MisP). We assume that misfolded protein can
be either refolded, ubiquitinated and degraded or at high
concentrations it may start to aggregate. Once an inclusion forms,
misfolded protein may be sequestered into the inclusion body,
including MisP bound to proteasomes.
Supporting Information
Figure S1 A)Western blot analysis with the phospho-HSP-27
antibody of cell extracts from U87MG cells co-transfected with
pcDNA empty vector, wild type p38 MAPK, kinase dead
p38MAPK, or hyper-active p38 MAPK expression constructs in
cells expressing HttQ25 or HttQ103. The analysis revealed that
phospho-Hsp27 levels were reduced in extracts from cells co-
transfected with kinase dead p38MAPK and showed a complete
abrogation of HSP-27 phosphorylation in cells treated with
SKF86002. The antibody raised against total HSP-27 was used
to detect total HSP-27 levels and actin served as a loading control.
B) Expression of p38 MAPK does not directly inhibit the
proteasome. Cells were transfected with either wild type p38
MAPK, kinase dead p38MAPK, or pcDNA control plasmids and
assayed for their ability to process a peptidylglutamyl- or
chymotrypsin-specific fluorogenic substrate. Cells were lysed
48 hours post-transfection and assayed in triplicates. The relative
activity of the proteasome was measured 12 hours after the
addition of the substrates. PI added to lysates was used as a control
to demonstrate the specificity of the PI inhibitor for the
chymotrypsin-like activity of the proteasome. Data was normalized
to the proteasome activity in lysates from cells transfected with a
pcDNA control vector. Experiments were performed in triplicate.
Error bars represent standard deviation of the mean.
Found at: doi:10.1371/journal.pcbi.1000944.s001 (0.28 MB TIF)
Figure S2 Distribution of polyQ monomers, oligomers and
inclusion bodies. Simulation output from 3 runs of the model
showing that the size of the oligomeric pool remains constant even
when inclusions form.
Found at: doi:10.1371/journal.pcbi.1000944.s002 (1.26 MB TIF)
Text S1 Model details.
Found at: doi:10.1371/journal.pcbi.1000944.s003 (0.14 MB
DOC)
Video S1 Time-lapse imaging of IB formation and UPS
dysfunction in U87MG cells transfected with HttQ103YFP-
pIRES-mRFPu. Live cell imaging was initiated at 24 hours post-
transfection and images were acquired every 10 minutes. Cells
were visualized under white light, and filters that detect YFP or
RFP. The brightfield and fluorescence emanating from the YFP
and RFP channels were merged to create a movie file. Images
were acquired using a 106objective for a total of 24 hours. At the
beginning of the movie HttQ103 is expressed throughout the cell.
At 36 hours (the half way point) many cells have formed an
inclusion body and have notable accumulation of the red reporter
protein (indicative of proteasome inhibition). Note that based on
their morphology many cells with IB appear to be viable at the end
of the movie.
Found at: doi:10.1371/journal.pcbi.1000944.s004 (5.79 MB
MOV)
Video S2 Time-lapse imaging of IB formation and UPS
dysfunction in U87MG cells transfected with HttQ103YFP-
pIRES-mRFPu. Live cell imaging was initiated at 24 hours post-
transfection and images acquired every 10 minutes. Cells were
visualized using filters that detect YFP or RFP. Fluorescent images
were merged to create a movie file. Images were acquired using a
106 objective for a total of 24 hours. At the beginning of the
movie HttQ103 is expressed throughout the cell. At 36 hours (the
half way point) many cells have formed an inclusion body and
have notable accumulation of the red reporter protein (indicative
of proteasome inhibition). Note that based on their morphology
many cells with IB appear to be viable at the end of the movie.
Found at: doi:10.1371/journal.pcbi.1000944.s005 (5.63 MB
MOV)
Video S3 Time-lapse imaging of U87MG cells transfected with
HttQ103YFP-pIRES-mRFPu treated with PI 24 hours post-
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transfection showing an increase of IB formation and UPS
dysfunction. Cells were visualized under white light, and filters that
detect YFP or RFP. The brightfield and fluorescence emanating
from the YFP and RFP channels were merged to create a movie
file. Images were acquired every 10 minutes using a 106objective
for a total of 24 hours. The movie shows rapid and progressive
accumulation of the mRFPu reporter protein (red colour) after the
addition of PI. This coincides with the formation of IB at an earlier
time point (30 hours). At the conclusion of the movie there are
considerably more IB and cell death events as compared to
untreated cells (videos S1 and S2).
Found at: doi:10.1371/journal.pcbi.1000944.s006 (6.83 MB
MOV)
Video S4 Time-lapse imaging of U87MG cells expressing
HttQ103YFP-pIRES-mRFPu treated with PI 24 hours post-
transfection. Cells were visualized using filters that detect YFP
or RFP. Fluorescence emanating from the YFP and RFP channels
was merged to create a movie which shows an increase of IB
formation and UPS dysfunction. Images acquired every 10 min-
utes using a 106 objective for a total of 24 hours. The movie
shows rapid and progressive accumulation of the mRFPu reporter
protein (red colour) after the addition of PI. This coincides with
the formation of IB at an earlier time point (30 hours). At the
conclusion of the movie there are considerably more IB and cell
death events as compared to untreated cells (videos S1 and S2).
Found at: doi:10.1371/journal.pcbi.1000944.s007 (4.26 MB
MOV)
Video S5 Time-lapse imaging of U87MG cells transfected with
HttQ103YFP-pIRES-mRFPu treated with BSO 24 hours post-
transfection. Treated cells displayed an increase in UPS dysfunc-
tion without IB formation. Cells were visualized under white light
and filters that detect YFP or RFP. The brightfield and
fluorescence emanating from the YFP and RFP channels was
merged to create a movie file. Images were acquired every
10 minutes using a 106 objective for a total of 24 hours. Cells
treated with BSO display a rapid and progressive accumulation of
the mRFPu reporter protein (red colour), but the frequency of IB
formation is not notably different than in untreated cells (videos S1
and S2).
Found at: doi:10.1371/journal.pcbi.1000944.s008 (4.76 MB
MOV)
Video S6 Time-lapse imaging of U87MG cells transfected with
HttQ103YFP-pIRES-mRFPu treated with BSO 24 hours post-
transfection showing an increase in UPS dysfunction without IB
formation. Cells were visualized using filters that detect YFP or
RFP. Fluorescence emanating from the YFP and RFP channels
was merged to create a movie file. Images were acquired every
10 minutes using a 106 objective for a total of 24 hours. Cells
treated with BSO display a rapid and progressive accumulation of
the mRFPu reporter protein (red colour), but the frequency of IB
formation is not notably different than in untreated cells (videos S1
and S2).
Found at: doi:10.1371/journal.pcbi.1000944.s009 (1.85 MB
MOV)
Video S7 Time-lapse imaging of U87MG cells transfected with
HttQ103YFP-pIRES-mRFPu pre-treated with SKF86002 two
hours prior to transfection. The movie shows a decrease in IB
formation and UPS dysfunction. Live cell imaging was initiated at
24 hours post-transfection, with images acquired every 10 min-
utes. Cells were visualized under white light, and filters that detect
YFP or RFP. The brightfield and fluorescence emanating from the
YFP and RFP channels were merged to create a movie file. Images
were acquired using a 106 objective for a total of 24 hours.
Throughout the movie there are fewer cells with IBs (relative to
untreated cells in movies S1 and S2). The levels of the mRFPu
reporter protein (red colour) remain lower than in untreated cells
and do not increase until late in the movie.
Found at: doi:10.1371/journal.pcbi.1000944.s010 (5.95 MB
MOV)
Video S8 Time-lapse imaging of U87MG cells transfected with
HttQ103YFP-pIRES-mRFPu pre-treated with SKF86002 two
hours prior to transfection. The movie shows a decrease in IB
formation and UPS dysfunction. Live cell imaging was initiated at
24 hours post-transfection and images were acquired every
10 minutes. Cells were visualized using filters that detect YFP or
RFP. Fluorescence emanating from the YFP and RFP channels
was merged to create a movie file. Images were acquired using a
106objective for a total of 24 hours. Throughout the movie there
are fewer cells with IBs (relative to untreated cells in videos S1 and
S2). The levels of the mRFPu reporter protein (red colour) remain
lower than in untreated cells and do not increase until late in the
movie.
Found at: doi:10.1371/journal.pcbi.1000944.s011 (1.17 MB
MOV)
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